---
symbol: "LLY"
name: "Eli Lilly"
date: 2026-08-06
change_pct: 3.994697304463106
direction: "up"
event_type: "earnings"
url: "https://perplo.app/why/LLY/2026-08-06"
updated_at: 2026-08-06T01:06:39.738Z
---

# Why Eli Lilly (LLY) rose 3.99% on August 6, 2026

Eli Lilly (LLY) rose 3.99% on August 6, 2026 — Eli Lilly beats, raises 2026 outlook on GLP-1 surge.

## What happened

Eli Lilly beat consensus earnings, raised full-year 2026 revenue guidance, and reported surging Zepbound and Mounjaro sales across obesity and diabetes segments.

## Why it moved

Higher revenue guidance on proven demand for GLP-1 obesity/diabetes drugs re-rates Lilly's near-term growth and justifies margin expansion; strong execution dispels prior caution about supply constraints and adoption…

## Why it matters

A core driver of the GLP-1 / Obesity supercycle — Lilly's outsized beat and raised outlook validate the entire theme's durability after recent narrative weakness from Hims pressure and prior Lilly caution, reinforcing…

## What would break the thesis

If Rx growth decelerates in coming quarters or supply constraints re-emerge and cap the raised outlook, the move will be reversed as a false signal.

## Sources

- [Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge](https://www.cnbc.com/2026/08/05/eli-lilly-lly-earnings-q2-2026.html) — CNBC
- [Why Eli Lilly Stock Climbed Today](https://finnhub.io/api/news?id=8db7b6882bc727e982f993c485b5d1df8b840684a25c8eba354b215d6812c54b) — Yahoo
- [Why is Eli Lilly stock surging today?](https://www.investing.com/news/stock-market-news/why-is-eli-lilly-stock-surging-today-93CH-4839011) — Investing.com

---

Trade LLY perpetual futures 24/7 onchain: https://perplo.app/asset/LLY